Filing Details

Accession Number:
0001209191-17-025174
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-04 17:39:42
Reporting Period:
2017-03-31
Filing Date:
2017-04-04
Accepted Time:
2017-04-04 17:39:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Cascadian Therapeutics Inc. CASC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356256 Dunseth Scott Myers C/O Cascadian Therapeutics, Inc.
2601 4Th Ave., Suite 500
Seattle WA 98121
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-31 2,000 $4.11 41,416 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct